Sevodyne. Welcome to sevodyne.co.uk Sevodyne (buprenorphine) transdermal patches are indicated for the treatment of non-malignant pain of moderate intensity when an opioid is necessary for obtaining adequate analgesia. Available as: Transdermal patch 5 microgram/hr Transdermal patch 10 microgram/hr Transdermal patch 20 microgram/hr Sevodyne extends the existing Category C Cost-saving Prolonged-release Product Portfolio from Aspire Pharma.

 

 

sevodyneanim800
Revision reference – Sevodyne_4_12/04/2017

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save